Evidence map›Paper›PMID 40021959›Full record

ArticleBMC infectious diseases2025

Evaluation of candidemia cases in the intensive care unit of a tertiary training hospital during the period of COVID-19 pandemic.

Fatma Yılmaz Karadağ, Derya Öztürk Engin, Aslıhan Ayşe Büber, Tülay Görmüş, Eyüp Arslan, Ayşe Şabablı Çetin, Selda Tekin, İsmet Sayan, Candan Bayri, Hakan Odabaşı and 2 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fatma Yılmaz KaradağDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey. dr_fatma@hotmail.com.
Derya Öztürk EnginDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Aslıhan Ayşe BüberDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Tülay GörmüşDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Eyüp ArslanDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Ayşe Şabablı ÇetinDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Selda TekinDepartment of Anesthesiology and Reanimation, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
İsmet SayanDepartment of Anesthesiology and Reanimation, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Candan BayriDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Emek Mahallesi, Namık Kemal cad. No 54 Sancaktepe, Istanbul, 34785, Turkey.
Hakan OdabaşıDepartment of Medical Microbiology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Nurten BakanDepartment of Anesthesiology and Reanimation, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Handan AnkaralıDepartment of Biostatistics, Istanbul Medeniyet University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany risk factors, including COVID-19 infection, lead to the development of invasive Candida infection in intensive care unit patients. The aim of this study was to evaluate the risk factors affecting mortality along with the clinical characteristics of candidemia patients.

methodsThis retrospective study was conducted among patients hospitalized at the Anesthesiology and Reanimation Clinic between June 2020 and December 2021. The clinical and laboratory characteristics of 165 patients with candidemia were recorded. The difference between patients with and without COVID-19 infection was evaluated statistically. Multivariate analysis was performed to determine factors affecting mortality.

resultsA total of 165 patients were included in the study, 52.1% of whom were male. The mean age of the patients was 66.5 (median 18-97) years. The percentage of patients with COVID-19 infection was 70.9%. The mean leukocyte count and aspartate transaminase, alanine transaminase, C-reactive protein, lactate dehydrogenase, ferritin, and D-dimer levels were significantly greater in COVID-19 patients than non COVID-19 patients (p < 0.05). The mortality rate in patients with candidemia was 80.2%. The presence of comorbidities, corticosteroid use, advanced age, and high ferritin and D-dimer levels negatively affected mortality, according to the multivariate analysis results. C. albicans was the most frequently isolated Candida species.

conclusionsWe detected higher mortality rates in patients with candidemia who were elderly, had comorbidities, received corticosteroid treatment and had elevated ferritin and D-dimer levels. When steroids are used, it is necessary to remember that this drug is a double-edged sword and to be careful of fungal infections.

Indexed as

CandidemiaCOVID-19Intensive Care UnitsAdolescentAdultAgedAged, 80 and overCandidaFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSARS-CoV-2Tertiary Care CentersCandidaCandidemiaCOVID-19Intensive care unitMortality

Identifiers

PMID40021959
PMCPMC11869554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.